- Investing Ideas
- /
- Belgian Large Cap High Growth Potential
Belgian Large Cap High Growth Potential
Results
2
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
2 companies
argenx
Market Cap: €32.0b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€524.20
7D
2.7%
1Y
55.4%
UCB
Market Cap: €25.9b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€136.30
7D
2.1%
1Y
12.5%